No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr2:172968000-172974800 |
Weak transcription |
Gastric |
stomach
|
2 |
chr2:172970600-172973600 |
Bivalent Enhancer |
Primary Natural Killer cells fromperipheralblood |
blood
|
3 |
chr2:172971200-172973600 |
Bivalent Enhancer |
Primary T cells fromperipheralblood |
blood
|
4 |
chr2:172971600-172973600 |
Bivalent Enhancer |
Primary monocytes fromperipheralblood |
blood
|
5 |
chr2:172971600-172975200 |
Bivalent Enhancer |
Fetal Thymus |
thymus
|
6 |
chr2:172971800-172974200 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
7 |
chr2:172971800-172974200 |
Weak transcription |
NHEK |
skin
|
8 |
chr2:172971800-172974400 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
9 |
chr2:172971800-172974600 |
Weak transcription |
HMEC |
breast
|
10 |
chr2:172972200-172973800 |
Bivalent Enhancer |
Primary T helper naive cells fromperipheralblood |
blood
|
11 |
chr2:172972600-172973800 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
12 |
chr2:172972600-172974200 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
13 |
chr2:172972600-172974400 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
14 |
chr2:172972600-172974800 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
15 |
chr2:172973000-172973600 |
Bivalent Enhancer |
Primary T helper cells PMA-I stimulated |
--
|
16 |
chr2:172973000-172978200 |
Weak transcription |
NHDF-Ad |
bronchial
|
17 |
chr2:172973200-172973600 |
Enhancers |
Foreskin Fibroblast Primary Cells skin02 |
Skin
|
18 |
chr2:172973200-172973600 |
Bivalent Enhancer |
Placenta Amnion |
Placenta Amnion
|
19 |
chr2:172973200-172973600 |
Flanking Bivalent TSS/Enh |
HepG2 |
liver
|
20 |
chr2:172973200-172973800 |
Bivalent Enhancer |
Stomach Smooth Muscle |
stomach
|
21 |
chr2:172973200-172974000 |
Bivalent Enhancer |
Primary T cells from cord blood |
blood
|
22 |
chr2:172973200-172974400 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
23 |
chr2:172973200-172974600 |
Bivalent Enhancer |
Primary hematopoietic stem cells G-CSF-mobilized Female |
--
|
24 |
chr2:172973400-172973600 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
25 |
chr2:172973400-172973600 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
26 |
chr2:172973400-172973600 |
Bivalent Enhancer |
H1 BMP4 Derived Mesendoderm Cultured Cells |
ES cell derived
|
27 |
chr2:172973400-172973600 |
Flanking Bivalent TSS/Enh |
iPS-15b Cell Line |
embryonic stem cell
|
28 |
chr2:172973400-172973600 |
Bivalent Enhancer |
Brain Germinal Matrix |
brain
|
29 |
chr2:172973400-172973800 |
Bivalent Enhancer |
Primary T regulatory cells fromperipheralblood |
blood
|
30 |
chr2:172973400-172974000 |
Bivalent Enhancer |
Foreskin Fibroblast Primary Cells skin01 |
Skin
|
31 |
chr2:172973400-172974800 |
Weak transcription |
H1 Derived Mesenchymal Stem Cells |
ES cell derived
|